Home > > > > Report Detail

Global Intramuscular Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 01-Nov-2022
No. of pages: 113
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Intramuscular Drug Delivery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Intramuscular Drug Delivery market. Further, it explains the major drivers and regional dynamics of the global Intramuscular Drug Delivery market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Antares Pharma

- Eli Lily

- Galaxo

- HMD pharmaceuticals

- Inovio Pharmaceuticals

- Merck

- Novartis

- Pacira Pharmaceuticals

- Pfizer

- Pharmajet

- Teva Pharmaceutical

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Intramuscular Drug Delivery Segment by Type

- Drug Molecule

- Delivery Devices

Intramuscular Drug Delivery Segment by Application

- Infectious Disease

- Oncology

- Autoimmune Diseases

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Intramuscular Drug Delivery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Intramuscular Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Intramuscular Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Intramuscular Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intramuscular Drug Delivery revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Intramuscular Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Intramuscular Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals and Pfizer, etc.

Global Intramuscular Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drug Molecule
1.2.3 Delivery Devices
1.3 Market by Application
1.3.1 Global Intramuscular Drug Delivery Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Intramuscular Drug Delivery Market Size (2017-2028)
2.2 Intramuscular Drug Delivery Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Intramuscular Drug Delivery Market Size by Region (2017-2022)
2.4 Global Intramuscular Drug Delivery Market Size Forecast by Region (2023-2028)
2.5 Global Top Intramuscular Drug Delivery Countries Ranking by Market Size
3 Intramuscular Drug Delivery Competitive by Company
3.1 Global Intramuscular Drug Delivery Revenue by Players
3.1.1 Global Intramuscular Drug Delivery Revenue by Players (2017-2022)
3.1.2 Global Intramuscular Drug Delivery Market Share by Players (2017-2022)
3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Intramuscular Drug Delivery Revenue
3.4 Global Intramuscular Drug Delivery Market Concentration Ratio
3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2021
3.5 Global Intramuscular Drug Delivery Key Players Head office and Area Served
3.6 Key Players Intramuscular Drug Delivery Product Solution and Service
3.7 Date of Enter into Intramuscular Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Intramuscular Drug Delivery Breakdown Data by Type
4.1 Global Intramuscular Drug Delivery Historic Revenue by Type (2017-2022)
4.2 Global Intramuscular Drug Delivery Forecasted Revenue by Type (2023-2028)
5 Global Intramuscular Drug Delivery Breakdown Data by Application
5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Intramuscular Drug Delivery Revenue by Company (2020-2022)
6.2 North America Intramuscular Drug Delivery Revenue by Type (2017-2028)
6.3 North America Intramuscular Drug Delivery Revenue by Application (2017-2028)
6.4 North America Intramuscular Drug Delivery Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Intramuscular Drug Delivery Revenue by Company (2020-2022)
7.2 Europe Intramuscular Drug Delivery Revenue by Type (2017-2028)
7.3 Europe Intramuscular Drug Delivery Revenue by Application (2017-2028)
7.4 Europe Intramuscular Drug Delivery Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Intramuscular Drug Delivery Revenue by Company (2020-2022)
8.2 Asia Pacific Intramuscular Drug Delivery Revenue by Type (2017-2028)
8.3 Asia Pacific Intramuscular Drug Delivery Revenue by Application (2017-2028)
8.4 Asia Pacific Intramuscular Drug Delivery Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Intramuscular Drug Delivery Revenue by Company (2020-2022)
9.2 Latin America Intramuscular Drug Delivery Revenue by Type (2017-2028)
9.3 Latin America Intramuscular Drug Delivery Revenue by Application (2017-2028)
9.4 Latin America Intramuscular Drug Delivery Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intramuscular Drug Delivery Revenue by Company (2020-2022)
10.2 Middle East and Africa Intramuscular Drug Delivery Revenue by Type (2017-2028)
10.3 Middle East and Africa Intramuscular Drug Delivery Revenue by Application (2017-2028)
10.4 Middle East and Africa Intramuscular Drug Delivery Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Antares Pharma
11.1.1 Antares Pharma Company Details
11.1.2 Antares Pharma Business Overview
11.1.3 Antares Pharma Intramuscular Drug Delivery Products and Services
11.1.4 Antares Pharma Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.1.5 Antares Pharma Intramuscular Drug Delivery SWOT Analysis
11.1.6 Antares Pharma Recent Developments
11.2 Eli Lily
11.2.1 Eli Lily Company Details
11.2.2 Eli Lily Business Overview
11.2.3 Eli Lily Intramuscular Drug Delivery Products and Services
11.2.4 Eli Lily Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.2.5 Eli Lily Intramuscular Drug Delivery SWOT Analysis
11.2.6 Eli Lily Recent Developments
11.3 Galaxo
11.3.1 Galaxo Company Details
11.3.2 Galaxo Business Overview
11.3.3 Galaxo Intramuscular Drug Delivery Products and Services
11.3.4 Galaxo Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.3.5 Galaxo Intramuscular Drug Delivery SWOT Analysis
11.3.6 Galaxo Recent Developments
11.4 HMD pharmaceuticals
11.4.1 HMD pharmaceuticals Company Details
11.4.2 HMD pharmaceuticals Business Overview
11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Products and Services
11.4.4 HMD pharmaceuticals Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.4.5 HMD pharmaceuticals Intramuscular Drug Delivery SWOT Analysis
11.4.6 HMD pharmaceuticals Recent Developments
11.5 Inovio Pharmaceuticals
11.5.1 Inovio Pharmaceuticals Company Details
11.5.2 Inovio Pharmaceuticals Business Overview
11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Products and Services
11.5.4 Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.5.5 Inovio Pharmaceuticals Intramuscular Drug Delivery SWOT Analysis
11.5.6 Inovio Pharmaceuticals Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Intramuscular Drug Delivery Products and Services
11.6.4 Merck Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.6.5 Merck Intramuscular Drug Delivery SWOT Analysis
11.6.6 Merck Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Intramuscular Drug Delivery Products and Services
11.7.4 Novartis Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.7.5 Novartis Intramuscular Drug Delivery SWOT Analysis
11.7.6 Novartis Recent Developments
11.8 Pacira Pharmaceuticals
11.8.1 Pacira Pharmaceuticals Company Details
11.8.2 Pacira Pharmaceuticals Business Overview
11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Products and Services
11.8.4 Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.8.5 Pacira Pharmaceuticals Intramuscular Drug Delivery SWOT Analysis
11.8.6 Pacira Pharmaceuticals Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Intramuscular Drug Delivery Products and Services
11.9.4 Pfizer Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.9.5 Pfizer Intramuscular Drug Delivery SWOT Analysis
11.9.6 Pfizer Recent Developments
11.10 Pharmajet
11.10.1 Pharmajet Company Details
11.10.2 Pharmajet Business Overview
11.10.3 Pharmajet Intramuscular Drug Delivery Products and Services
11.10.4 Pharmajet Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.10.5 Pharmajet Intramuscular Drug Delivery SWOT Analysis
11.10.6 Pharmajet Recent Developments
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Details
11.11.2 Teva Pharmaceutical Business Overview
11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Products and Services
11.11.4 Teva Pharmaceutical Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.11.5 Teva Pharmaceutical Recent Developments
12 Intramuscular Drug Delivery Market Dynamics
12.1 Intramuscular Drug Delivery Market Trends
12.2 Intramuscular Drug Delivery Market Drivers
12.3 Intramuscular Drug Delivery Market Challenges
12.4 Intramuscular Drug Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Intramuscular Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drug Molecule
Table 3. Key Players of Delivery Devices
Table 4. Global Intramuscular Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Intramuscular Drug Delivery Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Intramuscular Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Intramuscular Drug Delivery Revenue Market Share by Region (2017-2022)
Table 8. Global Intramuscular Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Intramuscular Drug Delivery Market Share by Players (2017-2022)
Table 10. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2021)
Table 11. Ranking of Global Top Intramuscular Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Intramuscular Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Intramuscular Drug Delivery Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Intramuscular Drug Delivery Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Intramuscular Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Intramuscular Drug Delivery Revenue Market Share by Type (2017-2022)
Table 19. Global Intramuscular Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Intramuscular Drug Delivery Revenue Market Share by Type (2023-2028)
Table 21. Global Intramuscular Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Intramuscular Drug Delivery Revenue Market Share by Application (2017-2022)
Table 23. Global Intramuscular Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Intramuscular Drug Delivery Revenue Market Share by Application (2023-2028)
Table 25. North America Intramuscular Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Intramuscular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Intramuscular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Intramuscular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Intramuscular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Intramuscular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Intramuscular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Intramuscular Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Intramuscular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Intramuscular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Intramuscular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Intramuscular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Intramuscular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Intramuscular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Intramuscular Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Intramuscular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Intramuscular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Intramuscular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Intramuscular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Intramuscular Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Intramuscular Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Intramuscular Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Intramuscular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Intramuscular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Intramuscular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Intramuscular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Intramuscular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Intramuscular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Intramuscular Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Intramuscular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Intramuscular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Intramuscular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Intramuscular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Intramuscular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Intramuscular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 60. Antares Pharma Company Details
Table 61. Antares Pharma Business Overview
Table 62. Antares Pharma Intramuscular Drug Delivery Product and Services
Table 63. Antares Pharma Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 64. Antares Pharma Intramuscular Drug Delivery SWOT Analysis
Table 65. Antares Pharma Recent Developments
Table 66. Eli Lily Company Details
Table 67. Eli Lily Business Overview
Table 68. Eli Lily Intramuscular Drug Delivery Product and Services
Table 69. Eli Lily Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 70. Eli Lily Intramuscular Drug Delivery SWOT Analysis
Table 71. Eli Lily Recent Developments
Table 72. Galaxo Company Details
Table 73. Galaxo Business Overview
Table 74. Galaxo Intramuscular Drug Delivery Product and Services
Table 75. Galaxo Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 76. Galaxo Intramuscular Drug Delivery SWOT Analysis
Table 77. Galaxo Recent Developments
Table 78. HMD pharmaceuticals Company Details
Table 79. HMD pharmaceuticals Business Overview
Table 80. HMD pharmaceuticals Intramuscular Drug Delivery Product and Services
Table 81. HMD pharmaceuticals Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 82. HMD pharmaceuticals Intramuscular Drug Delivery SWOT Analysis
Table 83. HMD pharmaceuticals Recent Developments
Table 84. Inovio Pharmaceuticals Company Details
Table 85. Inovio Pharmaceuticals Business Overview
Table 86. Inovio Pharmaceuticals Intramuscular Drug Delivery Product and Services
Table 87. Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 88. Inovio Pharmaceuticals Intramuscular Drug Delivery SWOT Analysis
Table 89. Inovio Pharmaceuticals Recent Developments
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Intramuscular Drug Delivery Product and Services
Table 93. Merck Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 94. Merck Intramuscular Drug Delivery SWOT Analysis
Table 95. Merck Recent Developments
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Intramuscular Drug Delivery Product and Services
Table 99. Novartis Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 100. Novartis Intramuscular Drug Delivery SWOT Analysis
Table 101. Novartis Recent Developments
Table 102. Pacira Pharmaceuticals Company Details
Table 103. Pacira Pharmaceuticals Business Overview
Table 104. Pacira Pharmaceuticals Intramuscular Drug Delivery Product and Services
Table 105. Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 106. Pacira Pharmaceuticals Intramuscular Drug Delivery SWOT Analysis
Table 107. Pacira Pharmaceuticals Recent Developments
Table 108. Pfizer Company Details
Table 109. Pfizer Business Overview
Table 110. Pfizer Intramuscular Drug Delivery Product and Services
Table 111. Pfizer Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 112. Pfizer Intramuscular Drug Delivery SWOT Analysis
Table 113. Pfizer Recent Developments
Table 114. Pharmajet Company Details
Table 115. Pharmajet Business Overview
Table 116. Pharmajet Intramuscular Drug Delivery Product and Services
Table 117. Pharmajet Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 118. Pharmajet Intramuscular Drug Delivery SWOT Analysis
Table 119. Pharmajet Recent Developments
Table 120. Teva Pharmaceutical Company Details
Table 121. Teva Pharmaceutical Business Overview
Table 122. Teva Pharmaceutical Intramuscular Drug Delivery Product and Services
Table 123. Teva Pharmaceutical Intramuscular Drug Delivery Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 124. Teva Pharmaceutical Recent Developments
Table 125. Intramuscular Drug Delivery Market Trends
Table 126. Intramuscular Drug Delivery Market Drivers
Table 127. Intramuscular Drug Delivery Market Challenges
Table 128. Intramuscular Drug Delivery Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intramuscular Drug Delivery Sales Market Share by Type: 2021 VS 2028
Figure 2. Drug Molecule Features
Figure 3. Delivery Devices Features
Figure 4. Global Intramuscular Drug Delivery Sales Market Share by Application: 2021 VS 2028
Figure 5. Infectious Disease Case Studies
Figure 6. Oncology Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Intramuscular Drug Delivery Report Years Considered
Figure 9. Global Intramuscular Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Intramuscular Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 11. Global Intramuscular Drug Delivery Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Intramuscular Drug Delivery Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Intramuscular Drug Delivery Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Intramuscular Drug Delivery Market Share by Players in 2021
Figure 15. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2021
Figure 17. North America Intramuscular Drug Delivery Revenue Market Share by Company in 2021
Figure 18. North America Intramuscular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 19. North America Intramuscular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 20. North America Intramuscular Drug Delivery Revenue Share by Country (2017-2028)
Figure 21. U.S. Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Intramuscular Drug Delivery Revenue Market Share by Company in 2021
Figure 24. Europe Intramuscular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 25. Europe Intramuscular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 26. Europe Intramuscular Drug Delivery Revenue Share by Country (2017-2028)
Figure 27. Germany Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 28. France Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Intramuscular Drug Delivery Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Intramuscular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Intramuscular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Intramuscular Drug Delivery Revenue Share by Region (2017-2028)
Figure 36. China Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 39. India Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 41. Taiwan Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 45. Philippines Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 46. Vietnam Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Intramuscular Drug Delivery Revenue Market Share by Company in 2021
Figure 48. Latin America Intramuscular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Intramuscular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Intramuscular Drug Delivery Revenue Share by Country (2017-2028)
Figure 51. Mexico Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Intramuscular Drug Delivery Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Intramuscular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Intramuscular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Intramuscular Drug Delivery Revenue Share by Country (2017-2028)
Figure 58. Turkey Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 60. U.A.E Intramuscular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 61. Antares Pharma Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 62. Eli Lily Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 63. Galaxo Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 64. HMD pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 65. Inovio Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 66. Merck Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 67. Novartis Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 68. Pacira Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 69. Pfizer Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 70. Pharmajet Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 71. Teva Pharmaceutical Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs